The Logistics Behind Personalized Medicine Delivery - Contract Pharma Article

February 21, 2018

Cryoport serves the biopharmaceutical market with leading-edge logistics solutions for biologic materials to ensure a safe delivery, such as regenerative medicine, including immunotherapies, stem cells, and CAR-T cells. Cryoport's goal is to help simplify global cold chain logistics through innovative technollogy, unmatched monitoring and data capture and support for the life sciences industry. In a recent Contract Pharma article, Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, discusses the importance of Cryoport's leading-edge logistics services for the safe delivery of temperature-sensitive personalized medicines. Read more >

Tags: Clinical Trials Logistics, Temperature Controlled Logistics